The underreporting of phase III chemo-therapeutic clinical trial data of older patients with cancer: A systematic review.

Volume: 11, Issue: 3, Pages: 369 - 379
Published: Apr 1, 2020
Abstract
null null Purpose null Inspired by the American Society of Clinical Oncology's recommendations to strengthen the evidence base for older adults with cancer, the purpose of this systematic review is to identify the reporting of treatment efficacy and adverse events specific to older adults with cancer in Phase III chemo-therapeutic clinical trials. This review also investigates the frequency with which these data points were reported in the...
Paper Details
Title
The underreporting of phase III chemo-therapeutic clinical trial data of older patients with cancer: A systematic review.
Published Date
Apr 1, 2020
Volume
11
Issue
3
Pages
369 - 379
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.